Our findings that FGFR signaling induces lymphangiogenic molecules in lymphatic endothelial cells, including VEGFR-2, VEGFR-3, netrin-1 and integrin α9, also validate the idea of FGF acting in a paracrine manner on tumor lymphatic endothelial cells. This evidence concerns the gene FLT4 and neoplasm.